| Market Cap | 3.12M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -416.71k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -42.00% |
| Sales | 89k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -50.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -83.00% |
| Recommedations | - | Quick Ratio | 0.17 | Shares Outstanding | 17.16M | 52W Low Chg | 17.00% |
| Insider Own | - | ROA | - | Shares Float | - | Beta | 5.74 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.17 |
| Gross Margin | 23.60% | Profit Margin | - | Avg. Volume | 12,695 | Target Price | - |
| Oper. Margin | -277.93% | Earnings Date | - | Volume | 125 | Change | -8.11% |
Innovative Holdings Alliance, Inc., a medical technology holding company, offers personal care products in North America. The company offers arthritis cream product, a topical ointment that is used for site specific applications to provide temporary relief of pain and inflammation associated with arthritis and other musculoskeletal conditions. The company was formerly known as Innovative Health Sciences, Inc. and changed its name to Innovative Holdings Alliance, Inc. in May 2011. Innovative Holdings Alliance, Inc. was founded in 1996 and is based in Alpharetta, Georgia.
